These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16308682)

  • 1. The intensive care support of patients with malignancy: do everything that can be done.
    Azoulay E; Afessa B
    Intensive Care Med; 2006 Jan; 32(1):3-5. PubMed ID: 16308682
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.
    Benoit DD; Depuydt PO; Vandewoude KH; Offner FC; Boterberg T; De Cock CA; Noens LA; Janssens AM; Decruyenaere JM
    Intensive Care Med; 2006 Jan; 32(1):93-9. PubMed ID: 16308681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fever in the neutropenic onco-hematologic patient: critical considerations].
    Garavelli PL
    Recenti Prog Med; 2006 May; 97(5):266. PubMed ID: 16838558
    [No Abstract]   [Full Text] [Related]  

  • 4. Urgent chemotherapy in hematological patients in the ICU.
    Moors I; Pène F; Lengline É; Benoit D
    Curr Opin Crit Care; 2015 Dec; 21(6):559-68. PubMed ID: 26539930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.
    Samuelson BT; Gernsheimer T; Estey E; Garcia DA
    Thromb Res; 2016 May; 141():104-5. PubMed ID: 26994682
    [No Abstract]   [Full Text] [Related]  

  • 6. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy.
    Kami M; Hori A; Takaue Y; Mutou Y
    Clin Infect Dis; 2002 Jul; 35(1):105-6; author reply 106-7. PubMed ID: 12060886
    [No Abstract]   [Full Text] [Related]  

  • 7. We all need support but can our patients help us to help them?
    Dalley C
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):516-517. PubMed ID: 30239388
    [No Abstract]   [Full Text] [Related]  

  • 8. The irreplaceable image: Nails changes in onco-hematologic patients.
    Vassallo C; Brazzelli V; Ardigò M; Borroni G
    Haematologica; 2001 Mar; 86(3):334-6. PubMed ID: 11255290
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care.
    Gordon AC; Oakervee HE; Kaya B; Thomas JM; Barnett MJ; Rohatiner AZ; Lister TA; Cavenagh JD; Hinds CJ
    Anaesthesia; 2005 Apr; 60(4):340-7. PubMed ID: 15766336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection.
    Grigull L; Schrauder A; Schmitt-Thomssen A; Sykora K; Welte K
    Infection; 2002 Oct; 30(5):267-71. PubMed ID: 12382084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fulminant hepatitis B as a result of reactivation in hematologic patient after chemotherapy combined with rituximab].
    Cantudo-Muñoz P; Anguita-Arance MM; Muñoz-Peña C; Amores-Antequera C
    Rev Esp Quimioter; 2015 Feb; 28(1):56-7. PubMed ID: 25690147
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy].
    Ueda T
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():202-6. PubMed ID: 23133953
    [No Abstract]   [Full Text] [Related]  

  • 13. [Traceability of oncohematological drugs through data capture codes].
    Escudero-Vilaplana B; Manso-Manrique M; García-Sanz E; Sánchez-Guerrero A
    Farm Hosp; 2017 Sep; 41(5):649-650. PubMed ID: 28847260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent research progress of rhythmic chemotherapy in patients with hematological neoplasm].
    Yu M; Zhou F; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):281-3. PubMed ID: 21569717
    [No Abstract]   [Full Text] [Related]  

  • 15. Postchemotherapy connective tissue diseases--more than just rheumatism?
    Amft N; D'Cruz D
    Lupus; 1996 Aug; 5(4):255-6. PubMed ID: 8869893
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of hematological malignancies in patients affected by renal failure.
    Niscola P; Vischini G; Tendas A; Scaramucci L; Giovannini M; Bondanini F; Romani C; Brunetti GA; Cartoni C; Cupelli L; Ferrannini M; Perrotti A; Del Poeta G; Palumbo R; de Fabritiis P
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):415-32. PubMed ID: 21417855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bendamustine: a new therapeutic option for hematologic malignancies.
    Cheson BD
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):631-3. PubMed ID: 18827785
    [No Abstract]   [Full Text] [Related]  

  • 18. The feasibility of early discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cordonnier C
    Haematologica; 2006 Feb; 91(2):150a. PubMed ID: 16461296
    [No Abstract]   [Full Text] [Related]  

  • 19. Noninvasive ventilation: trying to minimize harm?
    Keenan SP
    Crit Care Med; 2008 Oct; 36(10):2937-9. PubMed ID: 18812799
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombosis and DIC in hematological malignancies].
    Asakura H
    Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.